Quick Answer
IMMUCELL CORP /DE/ reported Research And Development Expense of $3.04 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed a decrease of -22.0% in Research And Development Expense from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), IMMUCELL CORP /DE/'s Research And Development Expense has grown by 84.9%.
- Historical annual values: Fiscal year 2025: $3.04 million | Fiscal year 2024: $3.90 million | Fiscal year 2023: $4.39 million | Fiscal year 2022: $4.49 million | Fiscal year 2021: $4.17 million | Fiscal year 2020: $4.35 million | Fiscal year 2019: $3.69 million | Fiscal year 2018: $3.52 million | Fiscal year 2017: $2.05 million | Fiscal year 2016: $1.24 million | Fiscal year 2015: $1.24 million | Fiscal year 2014: $2.18 million | Fiscal year 2013: $1.15 million | Fiscal year 2012: $917.6 thousand | Fiscal year 2011: $1.72 million | Fiscal year 2010: $1.49 million | Fiscal year 2009: $1.64 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: